Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Bowden

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Plos One|November 19, 2013
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort studyRachel Sacks-Davis, Campbell K Aitken, Peter Higgs, et al.
The Medical Journal of Australia|April 15, 2016
First reported outbreak of locally acquired hepatitis E virus infection in AustraliaChaturangi M Yapa, Catriona Furlong, Alexander Rosewell, et al.
Journal of Hepatology|January 22, 2008
96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis BChee-Kin Hui, Hai-Ying Zhang, Scott Bowden, et al.
Journal of Clinical Microbiology|August 8, 2006
Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapyChee-Kin Hui, Scott Bowden, Hai-Ying Zhang, et al.
Gut|October 18, 2015
Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leadersKumar Visvanathan, Geoff Dusheiko, Michelle Giles, et al.
Gastroenterology|June 10, 2004
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyBettina Werle-Lapostolle, Scott Bowden, Stephen Locarnini, et al.
Journal of Virology|April 2, 2010
Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigenDavid M Iser, Nadia Warner, Peter A Revill, et al.
Antiviral Therapy|August 24, 2007
Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis BGeorge K K Lau, Helen Cooksley, Ruy M Ribeiro, et al.
Journal of Gastroenterology and Hepatology|July 5, 2007
Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factorsAlexander J V Thompson, Anna Ayres, Lilly Yuen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2013
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virusGail V Matthews, Eric C Seaberg, Anchalee Avihingsanon, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Plos One|November 19, 2013
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort studyRachel Sacks-Davis, Campbell K Aitken, Peter Higgs, et al.
The Medical Journal of Australia|April 15, 2016
First reported outbreak of locally acquired hepatitis E virus infection in AustraliaChaturangi M Yapa, Catriona Furlong, Alexander Rosewell, et al.
Journal of Hepatology|January 22, 2008
96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis BChee-Kin Hui, Hai-Ying Zhang, Scott Bowden, et al.
Journal of Clinical Microbiology|August 8, 2006
Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapyChee-Kin Hui, Scott Bowden, Hai-Ying Zhang, et al.
Gut|October 18, 2015
Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leadersKumar Visvanathan, Geoff Dusheiko, Michelle Giles, et al.
Gastroenterology|June 10, 2004
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyBettina Werle-Lapostolle, Scott Bowden, Stephen Locarnini, et al.
Journal of Virology|April 2, 2010
Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigenDavid M Iser, Nadia Warner, Peter A Revill, et al.
Antiviral Therapy|August 24, 2007
Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis BGeorge K K Lau, Helen Cooksley, Ruy M Ribeiro, et al.
Journal of Gastroenterology and Hepatology|July 5, 2007
Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factorsAlexander J V Thompson, Anna Ayres, Lilly Yuen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2013
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virusGail V Matthews, Eric C Seaberg, Anchalee Avihingsanon, et al.
Pageof 10